BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 11122133)

  • 21. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients.
    Moreb JS; Kubilis PS; Mullins DL; Myers L; Youngblood M; Hutcheson C
    Bone Marrow Transplant; 1997 Jan; 19(2):101-6. PubMed ID: 9116605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
    Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O
    Bone Marrow Transplant; 2003 Jul; 32(2):217-23. PubMed ID: 12838288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin A-induced graft-versus-host disease following autologous bone marrow and stem cell transplantation in hematological malignancies of childhood.
    Gruhn B; Häfer R; Kosmehl H; Fuchs D; Zintl F
    Bone Marrow Transplant; 1998 May; 21(9):901-7. PubMed ID: 9613782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft.
    di Grazia C; Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A
    Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
    Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
    Bone Marrow Transplant; 1999 Sep; 24(6):637-40. PubMed ID: 10490729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies.
    Carral A; de la Rubia J; Martín G; Martínez J; Sanz G; Jarque I; Sempere A; Soler MA; Marty ML; Sanz MA
    Bone Marrow Transplant; 2002 May; 29(10):825-32. PubMed ID: 12058232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
    Reynolds C; Ratanatharathorn V; Adams P; Braun T; Silver S; Ayash L; Carson E; Eisbruch A; Dawson LA; McDonagh K; Ferrara J; Uberti J
    Bone Marrow Transplant; 2001 Apr; 27(8):801-7. PubMed ID: 11477436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New conditioning regimens for high risk marrow transplants.
    Jones RJ; Santos GW
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():15-7. PubMed ID: 2627618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of granulocyte-macrophage colony-stimulating factor in two children treated with cord blood transplantation.
    Vowels MR; Tiedemann K; Lam-Po-Tang R; Tucker DP
    Blood Cells; 1994; 20(2-3):249-54; discussion 254-5. PubMed ID: 7749102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autologous bone marrow transplantation in malignant hematologic diseases].
    Johnsen HE; Birgens H; Hansen NE
    Ugeskr Laeger; 1991 Jun; 153(25):1790-3. PubMed ID: 1853458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
    Mollee P; Morton AJ; Irving I; Durrant S
    Br J Haematol; 2001 Apr; 113(1):217-23. PubMed ID: 11328304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience.
    Laporte JP; Lesage S; Portnoï MF; Landman J; Rubinstein P; Najman A; Gorin NC
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S76-7. PubMed ID: 9715897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma.
    Pati AR; Godder KT; Abhyankar SH; Gee AP; Henslee-Downey PJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1081-3. PubMed ID: 8807118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.
    Del Cañizo Mf; Amigo Mf; Hernández JM; Sanz G; Núñez R; Carreras E; Alegre A; Cuesta B; Mataix R
    Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: a clinico-pathological study.
    Lim SH; Coleman S; Bull A; O'Callaghan U; Evely R; Booth M
    Bone Marrow Transplant; 1997 Jul; 20(1):83-5. PubMed ID: 9232264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine-induced graft-versus-host disease following autologous bone marrow transplantation in acute myeloid leukaemia.
    Talbot DC; Powles RL; Sloane JP; Rose J; Treleaven J; Aboud H; Helenglass G; Parikh P; Smith C; Rowley M
    Bone Marrow Transplant; 1990 Jul; 6(1):17-20. PubMed ID: 2202461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.
    Horowitz MM; Przepiorka D; Bartels P; Buell DN; Zhang MJ; Fitzsimmons WE; Erdman J; Huang C; Hodosh E; Maher R; Wingard JR
    Biol Blood Marrow Transplant; 1999; 5(3):180-6. PubMed ID: 10392964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
    Giralt S; Weber D; Colome M; Dimopoulos M; Mehra R; Van Besien K; Gajewski J; Andersson B; Khouri I; Przepiorka D; von Wolff B; Delasalle K; Korbling M; Seong D; Alexanian R; Champlin R
    J Clin Oncol; 1997 Feb; 15(2):667-73. PubMed ID: 9053492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.
    Kalwak K; Gorczyńska E; Toporski J; Turkiewicz D; Slociak M; Ussowicz M; Latos-Grazyńska E; Król M; Boguslawska-Jaworska J; Chybicka A
    Br J Haematol; 2002 Jul; 118(1):74-89. PubMed ID: 12100130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Autologous haematopoietic stem cell transplantation. Preliminary results of a regional multicentric study (author's transl)].
    Herve P; Rozenbaum A; Plouvier E; Lamy B; Flesh M; Farradji A; Bergerat JP; Adjizian JC; Behar C; Vu Van H; Philip T
    Nouv Presse Med; 1981 May; 10(24):2001-6. PubMed ID: 6114477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.